Чтение онлайн

124. Reglero-Real N., Colom B., Bodkin J. V., Nourshargh S. et al. Endothelial Cell Junctional Adhesion Molecules: Role and Regulation of Expression in Inflammation. Arterioscler Thromb Vasc Biol., 2016, Vol. 36, no.10, pp. 2048–2057. doi: 10.1161/ATVBAHA.116.307610.

125. Rizzo C., Grasso G., Castaniti G., Ciccia F., Guggino G. Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation. Vaccines, 2020, Vol. 8, no.2, pp.1–23. doi:10.3390/vaccines8020272.

126. Rock K. L., Kono H. The Inflammatory Response to Cell Death. Annu. Rev. Pathol. Mech. Dis., 2008, Vol. 3, pp.99–126. doi:10.1146/annurev.pathmechdis.3.121806.151456.

127. Rogers G. L., Shirley J. L., Zolotukhin I., Kumar S.P, Sherman A., Perrin G.Q…..Herzog R. W.. Plasmacytoid and conventional dendritic cells cooperate in cross-priming AAV capsid-specific CD8+ T cells. Blood, 2017, Vol. 129, no.24 pp.3184–3195. doi: 10.1182/blood-2016–11–751040.

128. Romero V., Fert-Bober J., Nigrovic P. A., Darrah E., Haque U. J., Lee D. M., van Eyk J., Rosen A., Andrate F. Immune-mediated pore- forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci. Transl. Med., 2013, Vol. 5, 209ra150. doi: 10.1126/scitranslmed.3006869.

129. Rosen A., Casciola-Rosen L. Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases. Annu. Rev. Immunol., 2016, 34:15.1–15.26. doi: 10.1146/annurev-immunol-032414–112205.

130. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol., 2000, Vol. 18, pp.217–242. doi: 10.1146/annurev.immunol.18.1.217.

131. Rot A., Ulrich H. von Andrian. Chemokines in innate and adaptive host defense: Basic Chemokinese Grammar for Immune Cells. Annu. Rev. Immunol., 2004, Vol. 22, pp. 891–928. doi: 10.1146/annurev.immunol.22.012703.104543.

132. Salomonsson S., Larsson P., Tengner P., Mellquist E., Hjelmstrom P., Wahren-Herlenius M. Expression of the B Cell-Attracting Chemokine CXCL13 in the Target Organ and Autoantibody Production Ectopic Lymphoid Tissue in the Chronic Inflammatory Disease SjoEgren's Syndrome. Scand. J. Immunol., 2002, Vol. 55, pp. 336–342. doi: 10.1046/j.1365–3083.2002.01058.x.

133. Sarelius I. Y., Glading A. J. Control of vascular permeability by adhesion molecules. Tissue Barriers. 2015, 3(1–2): e985954. doi: 10.4161/21688370.2014.985954.

134. Sato N., Beitz J. G., Kato J., Yamamoto M., Clark J. W., Calabresi P., Frackelton A. R. Jr. Platelet- derived growth factor indirectly stimulates angiogenesis in vitro. Am. J. Pathol., 1993, Vol. 142, no.4, pp. 1119–1130.

135. Scally S. W., Petersen J., Law S. C., Dudek N. L., Nel H. J., Loh K.L….Rossjohn J. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med., 2013, Vol. 210, no.12, pp.2569–2582. doi: 10.1084/jem.20131241.

136. Scheel T., Gursche A., Zacher J., Haupl T… Berek C. V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthr. Rheumat., 2011, Vol. 63, no. 1, pp. 63–72. doi: 10.1002/art.27767.

137. Schellekens G. A., de Jong B. A., van den Hoogen F. H., van de Putte L. B., van Venrooij W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Investig., 1998, Vol. 101, no.1, pp. 273–281. doi: 10.1172/JCI1316.

138. Schonbeck U., Brandt E., Petersen F., Flad H. D., Loppnow H., IL-8 specifically binds to endothelial but not to smooth muscle cells. J. Immunol., 1995, Vol. 154, no 5, pp. 2375–2383.

139. Segura E., Amigorena S. Cross-presentation by human dendritic cell subsets. Immunol.Lett., 2014, Vol. 158(1–2), pp.73–78. doi: 10.1016/j.imlet.2013.12.001.

140. Sharma D., Kanneganti T. D. The cell biology of inflammasomes: mechanisms of inflammasome activation and regulation. J. Cell Biol., 2016, Vol. 213, no. 6, pp.617–629. https://doi.org/10.1083/jcb.201602089.

141. Shikama Y., Kobayashi K., Kasahara K., Kara S. Granuloma formation by artificial microparticles in vitro. Macrophages and monokines play a critical role in granuloma formation. Am. J. Pathol., 1989, Vol. 134, no. 6, pp.1189–1199.

142. Silver J., Goyert S. M. Epitopes are the functional units of Ia molecules and form the molecular basis for disease susceptibility, human class II histocompatibility antigens. In: Ferrone S, Solheim BG, Moller E, editors. HLA class II antigens: a comprehensive review of structure and function. Berlin, Springer. 1985, p 32–48.

143. Skotnicki J. S., Zask A., Nelson F. C., Albright J. D., Levin J. I. Design and synthetic considerations of matrix metalloproteinase inhibitors. Ann. NY Acad. Sci., 1999, 30: 878, pp. 61–72. doi: 10.1111/j.1749–6632.1999.tb07674.x.

144. Sneller М. С. Granuloma formation, implications for the pathogenesis of vasculitis. Cleveland Clinic Journal of Medicine, 2002, Vol. 69, Supplement 2, pp. SII40–SII43. doi: 10.3949/ccjm.69.suppl_2.sii40.

145. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim. Biophys. Acta, 2004, Vol. 1654, pp. 13–22.

146. Spolski R, Leonard W. J. Interleukin-21: basic biology and implications for cancer and autoimmunity. Ann. Rev. Immunol., 2008, Vol. 26, pp.57–79. doi: 10.1146/annurev.immunol.26.021607.090316.

147. Steed A. L., Stappenbeck T. S. Role of viruses and bacteria-virus interactions in autoimmunity. Curr. Opin. Immunol., 2014, Vol. 31, pp.102–107. doi: 10.1016/j.coi.2014.10.006.

148. Stone R. C., Feng D., Deng J., Singh S., Yang L., Fitzgerald-Bocarsly P., Eloranta. M., Ronnblom L., Barnes B. J. Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons. Arthritis Rheum., 2012, Vol. 64, no.3, pp.788–798. doi: 10.1002/art.33395.

149. Stott D. I., Hiepe F., Hummel M., Steinhauser G., Berek C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with SjoE gren's syndrome. J. Clin. Invest., 1998, Vol.102, pp.938–946. doi: 10.1172/JCI3234.